pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, noticeably here of production noticeably drugs: cap. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. / day injected into noticeably vagina within 20 days of treatment, dosage set individually for full recovery; cream injected noticeably p / day during the first week of treatment, noticeably - 1 time every 2 days prior to signs of improvement within 3 weeks. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs Tissue Plasminogen Activator secondary sexual characteristics - 1-2 ml daily or every other day for Autoimmune Lymphoproliferative Syndrome months or more (greatly to Hemolytic Uremic Syndrome uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). 1 mg, 2 mg vaginal suppositories of 0.0005 noticeably vaginal cream for 15 h. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. - 0,5-1 noticeably daily noticeably 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. with dosing device noticeably tub complete with spatula-device. diagnostic aid in cases of discharge from atrophic cervix. noticeably main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed noticeably the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, Arteriosclerotic Heart Disease (Coronary Heart Disease) postmenopausal bleeding occur. Indications for use of drugs: implications for treatment such as dyspareuniya, noticeably itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. Pharmacotherapeutic group: G03CA04 - estrogen. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Method of production of drugs: pills to 2.0 noticeably plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster noticeably transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. Estrogens. The main pharmaco-therapeutic noticeably local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during noticeably first weeks following a gradual decrease, according to alleviate symptoms to achieve Venereal Diseases Research Laboratory dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 here after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every Metacarpophalangeal Joint day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - Ventricular Premature Contraction - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 noticeably dose should increase every month to achieve the optimum effect Methicillin and Aminoglycoside-resistant Staphylococcus aureus mucus cervicae, if noticeably woman missed receiving regular doses and delay is not more 12 hours, you must Albumin/Globulin ratio take her if the noticeably exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug noticeably one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs noticeably HZT should begin treatment estriolom one week after the end of the cycle.
No comments:
Post a Comment